Metraipolis › archive › dc_bfc9db1d8d0a

Pharmacogenomics in drug therapy: global regulatory guidelines for managing high-risk drug reactions — Europe PMC PMID:40993225

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40993225
DOI
10.1038/s41431-[numero omesso]-6
License (as archived)
solo-consultazione
Archived
2026-11-09T19:20:11.285Z
SHA-256 of the archived text
dfdc4bbe419272c194f110a672e24bd9a7fd98608388caa0e52f942330cccd4b
Stable URL of this page
https://metraipolis.com/documento/dc_bfc9db1d8d0a

How to cite

Pharmacogenomics in drug therapy: global regulatory guidelines for managing high-risk drug reactions — Europe PMC PMID:40993225 — Europe PMC (en), https://europepmc.org/article/MED/40993225 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bfc9db1d8d0a (Metraipolis archive dc_bfc9db1d8d0a, sha256 dfdc4bbe419272c194f110a672e24bd9a7fd98608388caa0e52f942330cccd4b)
BibTeX
@misc{dcbfc9db1d8d0a,
  title = {Pharmacogenomics in drug therapy: global regulatory guidelines for managing high-risk drug reactions — Europe PMC PMID:40993225},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40993225},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bfc9db1d8d0a; sha256 dfdc4bbe419272c194f110a672e24bd9a7fd98608388caa0e52f942330cccd4b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40993225. Agents can read the archived copy with the MCP tool read_document.